Related Experiment Video
Updated: Jun 26, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
OLDES: new solution for long-term diabetes compensation management
D Novak1, O Stepankova, M Mraz
1Department of Cybernetics, Czech Technical University in Prague, Czech Republic. xnovakd1@labe.felk.cvut.cz
Summary
The EU project OLDES developed an affordable home e-services platform for older adults, integrating entertainment and health monitoring. A pilot study demonstrated its use for diabetes type II management through continuous health tracking and personalized dietary advice.
Area of Science:
- Gerontology
- Health Informatics
- Human-Computer Interaction
Background:
- Aging populations require accessible and affordable technology solutions for independent living.
- Existing e-services often lack user-friendliness and integration for older adults.
- The Older People's e-services at home (OLDES) project addresses these gaps.
Purpose of the Study:
- To develop a low-cost, user-friendly e-services platform for older adults' home use.
- To integrate entertainment and healthcare functionalities into a single platform.
- To pilot the platform for managing chronic conditions, specifically diabetes type II.
Main Methods:
- Development of a PC-based platform adhering to the $100 device paradigm.
- Implementation of user-centered design for intuitive software interfaces.
- Integration of interactive food scales for daily consumption tracking.
- Continuous monitoring of glucose, blood pressure, and weight.
- Provision of personalized health advice based on user data.
Main Results:
- The OLDES platform successfully integrated entertainment and healthcare services.
- A pilot case study demonstrated feasibility for diabetes type II management.
- Users could input food consumption data via interactive scales and receive advice.
- The system facilitated continuous monitoring of key health indicators.
Conclusions:
- The OLDES platform offers a viable, low-cost solution for enhancing older adults' quality of life at home.
- The integrated approach supports both social engagement and chronic disease management.
- User-centered design is crucial for the adoption and effectiveness of e-health technologies among the elderly.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...